Maternal Nutrition – Monthly Progress Report (Non-Cumulative)

Year   
Normalized   

Quarterly Progress Report (QPR) on age-group wise service deliveries and information on distribution of Iron and Folic Acid (IFA) syrup and tablets- Pink, Blue & Red, Albendazole tablets among the 6 focused age groups. The information is derived on the basis of data updates available from HMIS indicators (Numerator) calculated using the eligible age specific respective denominators for each age group. *The GOI quarter reporting year starts from April and ends in March of the subsequent year (Q1-April to June, Q2-July to September, Q3- October to December and Q4 January to March (of subsequent year)).

Maternal Nutrition in Percentage

India

Maternal Nutrion KPI

ANC Services


Year       _Nil       _Nil_       Apr
2021-2289.6
2021-2276.2
HMIS 1.2.4:
Percentage of pregnant women (PW) given 180 Iron and Folic Acid (IFA) tablets (Registered Pregnancy)
2020-2185.7
HMIS 1.2.4:
Percentage of pregnant women (PW) given 180 Iron and Folic Acid (IFA) tablets (Registered Pregnancy)
2019-2089.3
HMIS 1.2.4:
Percentage of pregnant women (PW) given 180 Iron and Folic Acid (IFA) tablets (Registered Pregnancy)
2018-1977.5
HMIS 1.2.4:
Percentage of pregnant women (PW) given 180 Iron and Folic Acid (IFA) tablets (Registered Pregnancy)
2017-1866.6
2021-2250.3
2021-2242.8
HMIS 1.2.6:
Percentage of pregnant women (PW) given one Albendazole tablet after 1st trimester
2020-2151.4
HMIS 1.2.6:
Percentage of pregnant women (PW) given one Albendazole tablet after 1st trimester
2019-2040.4
HMIS 1.2.6:
Percentage of pregnant women (PW) given one Albendazole tablet after 1st trimester
2018-1934.7
HMIS 1.2.6:
Percentage of pregnant women (PW) given one Albendazole tablet after 1st trimester
2017-1822.5
2021-2285.1
HMIS 1.1:
Percentage of pregnant women (PW) registered for ANC
2020-2158.1
2020-2158.1
HMIS 1.1:
Percentage of pregnant women (PW) registered for ANC
2019-2095.0
2019-2095.0
HMIS 1.1:
Percentage of pregnant women (PW) registered for ANC
2018-1995.0
2018-1995.0
HMIS 1.1:
Percentage of pregnant women (PW) registered for ANC
2017-1895.0
2017-1895.0
HMIS 1.2.7:
Number of pregnant women (PW) who received 4 or more ANC check ups
2020-2170.8
HMIS 1.2.7:
Number of pregnant women (PW) who received 4 or more ANC check ups
2019-2069.8
HMIS 1.2.7:
Number of pregnant women (PW) who received 4 or more ANC check ups
2018-1965.0
HMIS 1.2.7:
Number of pregnant women (PW) who received 4 or more ANC check ups
2017-1850.3
HMIS 1.2.5:
Number of PW given 360 Calcium tablets
2020-2174.3
HMIS 1.2.5:
Number of PW given 360 Calcium tablets
2019-2060.5
HMIS 1.2.5:
Number of PW given 360 Calcium tablets
2018-1949.4
HMIS 1.2.5:
Number of PW given 360 Calcium tablets
2017-1831.1
HMIS 25.1.2:
Number of Pregnant Women provided - Free Diet under JSSK
2020-2140.8
HMIS 25.1.2:
Number of Pregnant Women provided - Free Diet under JSSK
2019-2038.9
HMIS 25.1.2:
Number of Pregnant Women provided - Free Diet under JSSK
2018-1933.5
HMIS 25.1.2:
Number of Pregnant Women provided - Free Diet under JSSK
2017-1834.1
IFA Supplement


Year       _Nil       _Nil_       Apr
2021-2264.6
HMIS 1.4.2:
Percentage of pregnant women (PW) having Hb level<11 (tested cases)(7.1 to 10.9)
2020-2165.7
HMIS 1.4.2:
Percentage of pregnant women (PW) having Hb level<11 (tested cases)(7.1 to 10.9)
2019-2068.3
HMIS 1.4.2:
Percentage of pregnant women (PW) having Hb level<11 (tested cases)(7.1 to 10.9)
2018-1965.4
HMIS 1.4.2:
Percentage of pregnant women (PW) having Hb level<11 (tested cases)(7.1 to 10.9)
2017-1859.2
2021-223.1
HMIS 1.4.3:
Percentage of pregnant women (PW) having Hb level<7 (tested cases)
2020-213.0
HMIS 1.4.3:
Percentage of pregnant women (PW) having Hb level<7 (tested cases)
2019-203.3
HMIS 1.4.3:
Percentage of pregnant women (PW) having Hb level<7 (tested cases)
2018-193.2
HMIS 1.4.3:
Percentage of pregnant women (PW) having Hb level<7 (tested cases)
2017-182.9
2021-221.7
HMIS 1.4.4:
Percentage of pregnant women (PW) having severe anemia (Hb<7) treated
2020-212.0
HMIS 1.4.4:
Percentage of pregnant women (PW) having severe anemia (Hb<7) treated
2019-202.1
HMIS 1.4.4:
Percentage of pregnant women (PW) having severe anemia (Hb<7) treated
2018-191.7
HMIS 1.4.4:
Percentage of pregnant women (PW) having severe anemia (Hb<7) treated
2017-181.3
HMIS 1.4.2 + HMIS 1.4.32020-2134.4
HMIS 1.4.2 + HMIS 1.4.32019-2035.8
HMIS 1.4.2 + HMIS 1.4.32018-1934.3
HMIS 1.4.2 + HMIS 1.4.32017-1831.0
2021-220.0
2021-2278.1
HMIS 6.3:
Number of mothers provided full course of 180 Iron and Folic Acid (IFA) tablets after delivery
2020-2164.9
HMIS 6.3:
Number of mothers provided full course of 180 Iron and Folic Acid (IFA) tablets after delivery
2019-2056.8
HMIS 6.3:
Number of mothers provided full course of 180 Iron and Folic Acid (IFA) tablets after delivery
2018-1949.4
HMIS 6.3:
Number of mothers provided full course of 180 Iron and Folic Acid (IFA) tablets after delivery
2017-1836.5
HRP


Year       _Nil       _Nil_       Apr
HMIS 1.3.1.a:
Out of the new cases of PW with hypertension detected and case managed at Institutions
2020-211.6
HMIS 1.3.1.a:
Out of the new cases of PW with hypertension detected and case managed at Institutions
2019-201.3
HMIS 1.3.1.a:
Out of the new cases of PW with hypertension detected and case managed at Institutions
2018-191.2
HMIS 1.3.1.a:
Out of the new cases of PW with hypertension detected and case managed at Institutions
2017-181.0
HMIS 1.5.3:
Number of PW given insulin out of total tested positive for GDM
2020-210.1
HMIS 1.5.3:
Number of PW given insulin out of total tested positive for GDM
2019-200.1
HMIS 1.5.3:
Number of PW given insulin out of total tested positive for GDM
2018-190.1
HMIS 1.5.3:
Number of PW given insulin out of total tested positive for GDM
2017-180.1
HMIS 1.3.1:
New cases of PW with hypertension detected
2020-212.1
HMIS 1.3.1:
New cases of PW with hypertension detected
2019-201.8
HMIS 1.3.1:
New cases of PW with hypertension detected
2018-191.9
HMIS 1.3.1:
New cases of PW with hypertension detected
2017-182.0
HMIS 1.5.2:
Number of PW tested positive for GDM
2020-210.5
HMIS 1.5.2:
Number of PW tested positive for GDM
2019-200.4
HMIS 1.5.2:
Number of PW tested positive for GDM
2018-190.4
HMIS 1.5.2:
Number of PW tested positive for GDM
2017-180.4
Stock


Year       _Nil       _Nil_       Apr
2021-2229.5
2021-2229.5
HMIS 19.6:
Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult)
2020-2122.9
2020-2122.9
HMIS 19.6:
Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult)
2019-2030.6
2019-2030.6
HMIS 19.6:
Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult)
2018-1928.4
2018-1928.4
HMIS 19.6:
Number of stocks available for Iron and Folic Acid (IFA) tablets - Red (Adult)
2017-1815.2
2017-1815.2
HMIS 19.15:
Number of stocks available for Albendazole tablets
2020-2140.3
HMIS 19.15:
Number of stocks available for Albendazole tablets
2019-2011.0
HMIS 19.15:
Number of stocks available for Albendazole tablets
2019-2090.5
HMIS 19.15:
Number of stocks available for Albendazole tablets
2018-1916.5
HMIS 19.15:
Number of stocks available for Albendazole tablets
2018-1973.5
HMIS 19.15:
Number of stocks available for Albendazole tablets
2017-186.1
HMIS 19.15:
Number of stocks available for Albendazole tablets
2017-1829.9
HMIS 19.16:
Number of Stocks available for Iron Calcium Tablets
2020-2121.4
HMIS 19.16:
Number of Stocks available for Iron Calcium Tablets
2019-2012.4
HMIS 19.16:
Number of Stocks available for Iron Calcium Tablets
2018-196.4
HMIS 19.16:
Number of Stocks available for Iron Calcium Tablets
2017-183.4